18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1.

Karolinska Institutet
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.

Karolinska Institutet
Towards small molecule inhibitors of mono-ADP-ribosyltransferases.

Karolinska Institutet
Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis.

Karolinska Institutet
Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity.

Karolinska Institutet
Synthesis and evaluation of [¹8F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).

Karolinska Institutet
Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor.

Karolinska Institutet
Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B).

Karolinska Institutet
Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction.

Karolinska Institutet
Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis.

Karolinska Institutet
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.

Karolinska Institutet
Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability.

Karolinska Institutet
Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).

Karolinska Institutet
Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines.

Karolinska Institutet
Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems.

Karolinska Institutet
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

Karolinska Institutet
Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.

Schering-Plough Research Institute